Medicine & Healthcare Infectious disease

News

21 Jan 2022
A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against the Omicron variant, in a pair of papers published in Nature Medicine.
13 Jan 2022
The dengue virus alters mosquito behaviour in a way that makes it three times more efficient at transmitting infection.
Asia research News - Editor's Choice
10 Jan 2022
Unveiling substructures at the edge of the Galaxy, Nanodiamonds key to efficient hydrogen purification, How SARS-CoV-2 evades our immune system, A Zika hijacking with devastating impacts & Finding the right story for your audience, all in the January Editor's Choice.
15 Dec 2021
In a recent study published in the Journal of Extracellular Vesicles researchers from Kanazawa University have visualized structural changes on the surface of SARS-CoV-2 that enable it to enter human cells.
Asia research News - Editor's Choice
09 Dec 2021
Micro-plastics cross blood brain barrier, Stomach cancer atlas, Omicron variant isolated, 120-year-old reaction turned on its head and Reporting through the coup, all in the December Editor's Choice. Plus our latest podcast: Decentralization and Democracy in Myanmar.
The expression of the immune response gene ​​NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Ji-Seung Yoo, Koichi Kobayashi).
07 Dec 2021
Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.
Immunofluorescence staining of uninfected and infected Vero E6 cells
30 Nov 2021
Researchers at the Department of Microbiology at The University of Hong Kong have succeeded in the isolation of SARS-CoV-2 Omicron variant from clinical specimens. This is the first known research team in Asia that has succeeded in isolating the Omicron variant. The isolated variant will enable the development and production of vaccines against Omicron, which has been designated as a "variant of concern" by the World Health Organization.
24 Nov 2021
Researchers from the Osaka City University Graduate School of Medicine have shown in patients with early-stage hepatocellular carcinoma who received cancer treatment that eliminating the hepatitis C virus with a direct-acting antiviral treatment reduces the risk of the liver cancer progression and increases overall patient survival.
16 Nov 2021
Scientists are turning to genomics to better understand the epidemiology of malaria and to inform control and elimination interventions and strategies. In the Lake Victoria region of Kenya, malaria burden remains very high despite more than a decade of intense control activities. A team of researchers from Osaka City University, Nagasaki University, London School of Hygiene and Tropical Medicine, and Mount Kenya University generated whole Plasmodium falciparum genome sequences from the lake region. Their analyses revealed that malaria parasites from this region appear distinct from other parasites from East Africa, while frequencies of known drug resistance markers were similar to those in other East African parasite populations. Their findings will help to develop improved surveillance tools to determine parasite transmission routes and aid clinical disease management.
Transmission electron micrograph of the Yezo virus.
04 Oct 2021
A previously unknown virus that can infect humans and cause disease has been identified by scientists in Japan. The novel infectious virus, named Yezo virus and transmitted by tick bites, causes a disease characterized by fever and a reduction in blood platelets and leucocytes.
UNESCO and the L'Oréal Foundation International Prize for Women in Science 2022
01 Oct 2021
Paris, 29 September — UNESCO and the L'Oréal Foundation are unveiling the winners of this year’s International Prize for Women in Science, which honours five eminent women scientists with exceptional careers from the five regions of the world, as it has done annually since 1998.
Stop TB partnership
29 Sep 2021
Geneva, 28 September 2021 – The Stop TB Partnership today released new data showing how the COVID-19 pandemic and dismally low levels of funding represent the main barriers to achieving the United Nations Sustainable Development Goals of ending TB by 2030.
elite antibodies defeat coronavirus variants
24 Sep 2021
Scientists created “elite” antibodies that can beat a broad range of coronavirus strains, including Delta, using a new technique that dramatically speeds up discovering potent antibody candidates.
Schematic representation of effects of AHR agonists.
10 Sep 2021
Researchers have identified a potential reason why lower numbers of COVID cases have appeared amongst smokers compared to non-smokers, even as other reports suggest smoking increases severity of the disease.
02 Sep 2021
A rapid way to track an elusive part of the immune system will bring better vaccine strategies
19 Aug 2021
The finding could underpin a “dream” vaccine that covers not only SARS-CoV-2 and its known variants of concern (VOCs), but also future VOCs and other animal coronaviruses with known potential to cause severe disease in humans
The fluorescence polarization immunoassay developed to detect and quantify antibodies against SARS-CoV-2
15 Jul 2021
Scientists have developed a rapid, highly accurate test to detect antibodies against the spike protein of SARS-CoV-2 in human serum, opening a new avenue for understanding the full extent of the pandemic and evaluating the effectiveness of vaccines.
19 May 2021
Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.
long tailed macaque
13 May 2021
A simple tool allows researchers to track how different subpopulations of the Plasmodium knowlesi parasite are changing over time.
Reverse genetics for SARS-CoV-2 by the CPER method.
13 Apr 2021
Researchers from Osaka University and Hokkaido University develop a system for analyzing mutations in SARS-CoV-2 that is much simpler and faster than existing methods.
24 Mar 2021
Study shows that antibody longevity varies widely from 40 days to as long as several decades and not everyone who has recovered from COVID-19 is immune from reinfection. Individuals with low levels of neutralising antibodies may still be protected if they have robust T-cell immunity. Blood tests and a computer algorithm suggest annual vaccinations might be needed for some individuals to prevent future outbreaks of COVID-19.
Hokkaido University
19 Mar 2021
On March 19, 2021, Hokkaido University, Robotic Biology Institute Inc., iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) toward the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater.
The Northern Pintail, a migratory duck
11 Mar 2021
Scientists have discovered a route of introduction for High Pathogenicity Avian Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.
Hirofumi Sawa, MD, Ph.D.
04 Mar 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Chie Nakajima, DVM, Ph.D. and Kyoko Hayashida, DVM, Ph.D.
25 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Akihiko Sato, DVM, Ph.D.
18 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
16 Feb 2021
The 2nd Call for Proposal for the Small Grant Program "Staying Resilient Amid the Pandemic in Southeast Asia" is now open!
Yoshihiro Sakoda, DVM, Ph.D.
12 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Hiroshi Kida, DVM, Ph.D
04 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
23 Nov 2020
Taskforce will look into COVID-19 origins, leveraging expertise in One Health, outbreak investigation, virology, lab biosecurity and disease ecology.

Events

23 Nov 2020 to 24 Nov 2020
Global health emergencies look set to be a part of our lives. What awaits us in 2021 and what lessons can we draw from COVID-19 coverage? How can we support newsrooms and journalists for more informed and impactful journalism about global scientific, technical and human challenges? What role does journalism play in seeking solutions for a better world that is both healthy, and sustainable?

Researchers

Prof. Tomoharu Yasuda
Prof. Tomoharu Yasuda's laboratory studies how immune system is regulated through the antigen receptor, intracellular signaling and lymphocyte programming.
Picture of Prof. Antonio Bertoletti
Prof. Antonio Bertoletti's current research focuses on the development of new immunological based therapies (TCR-redirected T cells, HLA-peptide specific antibodies) for the treatment of HBV and Hepatocellular carcinoma (HCC), and the characterization of human intra-sinusoidal hepatic immune system.
Professor Linfa Wang is a Professor with the Emerging Infectious Diseases Programme at Duke-NUS Medical School, Singapore.
Associate Professor Sophia Archuleta is the Head and Senior Consultant of the Division of Infectious Diseases at the National University Hospital, Singapore.
Ashley St. John
Prof. Ashley St. John is an expert in viral immunology and emerging infectious diseases, such as dengue and Zika viruses. She heads the Laboratory of Immunity and Immune Pathology at Duke-NUS Medical School.